• This record comes from PubMed

Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics

. 1998 ; 43 (6) : 683-6.

Language English Country United States Media print

Document type Journal Article, Research Support, Non-U.S. Gov't

The interaction of type-I beta-lactamases from Enterobacter cloacae with diverse beta-lactam compounds was examined. The ability of penicillin and cefoxitin to induce beta-lactamase production in this strain was assessed. The effect of beta-lactamase inhibitors was measured on beta-lactamase extracts and on intact cells. E. cloacae 78 strain is a stably derepressed mutant showing limited susceptibility to a number of antibiotics except imipenem. Imipenem would therefore be the appropriate choice for therapy of infections caused by stably derepressed mutants of Enterobacter sp. producing type-I beta-lactamases.

See more in PubMed

J Antimicrob Chemother. 1986 Jan;17(1):45-50 PubMed

Antimicrob Agents Chemother. 1986 Jul;30(1):6-10 PubMed

Enferm Infecc Microbiol Clin. 1996 Mar;14(3):171-6 PubMed

J Antimicrob Chemother. 1982 Apr;9(4):287-96 PubMed

Antimicrob Agents Chemother. 1991 Jan;35(1):73-8 PubMed

J Infect Dis. 1986 Nov;154(5):792-800 PubMed

Enferm Infecc Microbiol Clin. 1995 May;13(5):278-82 PubMed

J Antimicrob Chemother. 1985 Jul;16(1):31-42 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...